期刊文献+

低剂量氟尿嘧啶长期持续静脉滴注治疗晚期结肠癌48例 被引量:1

Long Term Continuous Intravenous Drip Infusion of Low Dose Fluorouracil for Forty-eight Patients with Advanced Colon Cancer
下载PDF
导出
摘要 目的观察低剂量氟尿嘧啶(5-Fu)长期持续静脉滴注治疗晚期结肠癌的临床疗效和不良反应。方法48例经病理确诊的Ⅳ期结肠癌患者给予5-Fu300mg·d^-1经便携式微量输液泵持续静脉滴注10d,28d为1周期,治疗2~4周期,每2周期后以评价疗效和不良反应。结果CR0例,PR4例,SD21例,PD23例,有效率为8.33%,临床获益率为52.08%。不良反应主要为Ⅰ、Ⅱ度消化道反应及骨髓抑制。结论低剂量5-Fu长期持续静脉滴注治疗晚期结肠癌,安全性高,耐受性好,费用低,值得临床推广。 Objective To investigate the clinical outcome and toxicities of long term continuous intravenous drip infusion of low dose fluorouracil (5-Fu) for patients with advanced colon cancer. Methods Forty-eight patients with colon cancer diagnosed by pathology were treated with long term continuous intravenous drip infusion of 5-Fu ( 300 mg · d^ -1 ) through portable pumps for ten days. Every 28 days was one cycle, and each patient was treated for 2 - 4 cycles. The effect evaluation was conducted after every 2 cycles. The toxicities evaluation was performed. Re- suits Zero case was CR,4 cases were PR, 21 cases were SD, and 23 cases were PD. The response rate was 8.33% ,the clinical benefit rate was 52.08%. The most common toxicities were mainly Ⅰ and Ⅱ level of gastrointestinal reaction and bone marrow suppression. Conclusion Long term continuous intravenous drip infusion of low dose 5-Fu is safe and effect for advanced colon cancer.
出处 《肿瘤基础与临床》 2016年第6期483-485,共3页 journal of basic and clinical oncology
关键词 氟尿嘧啶 晚期结肠癌 化疗 持续静脉滴注 fluorouracil advanced colon cancer chemotherapy continuous intravenous drip infusion
  • 相关文献

参考文献3

二级参考文献25

  • 1朱陵君,黄普文,卢凯华,张锦英,束永前.多西他赛联合顺铂和氟尿嘧啶治疗进展期胃癌48例临床分析[J].肿瘤防治杂志,2005,12(23):1803-1805. 被引量:9
  • 2Jassem J, Pienkowski T, Pluzanska A, et al. Doxorubiein and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial [ J ]. Onkologie, 2009,32 ( 8-9 ) : 468- 472.
  • 3Chang AY, Lopes G, Hsin KW, et al. Phase II trial of 5-fluorouracil/ leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma:a cancer therapeutics research group study [ J ]. Clin Colorectal Cancer, 2007,6 ( 9 ) : 646- 651.
  • 4Bae WK,Hwang JE,Shim HJ,et al. Phase II study of docetaxel,cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer [ J ]. Cancer Chemother Pharmaco1,2010,65 ( 3 ) :589-595.
  • 5Longley DB, Harkin DP, Johnston PG, et al. 5-fluorouracil: Mechanisms of action and clinical strategies[ JJ. Nat Rev Cancer,2003,3: 330-338.
  • 6Hoff PM, Ansari R, Batist G, ct al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic coloreetal cancer: results of a randomized phase 1H study[J]. J Clin Oncol,2001,19(8) :2282-2292.
  • 7Folkman J. Anti-angiogenesis : new concept for therapy of solid tumors [J]. Ann Surg,1972,175(3) :409-416.
  • 8Hanahan D, Bergers G, Bergsland E. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice [ J ]. J Clin Invest,2000,105 (8) : 1045-1047.
  • 9Colleoni M, Rocca A, Sandri MT, et al. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels[J]. Ann Oncol, 2002,13 ( 1 ) : 73-80.
  • 10Glode LM, Barqawi A, Crighton F, et al. Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma[ J ]. Caneer,2003,98 ( 8 ) : 1643-1648.

共引文献11

同被引文献6

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部